Mantige Varalaxmi

INNOVATIVE APPROACHES IN RATIONAL DRUG DESIGN FOR THE DEVELOPMENT OF ANTI-TUBERCULAR AGENTS:

Objective :

• To contribute to the development of novel anti-tubercular agents using innovative rational drug design strategies.
• To optimize therapeutic efficacy and reduce drug resistance through structure-based and computational drug discovery techniques.
• To enhance target specificity by leveraging modern tools in molecular modeling and bioinformatics.

Objective :

• To employ structure-based virtual screening techniques for the identification and evaluation of pyrimidine analogs as potential anti-tubercular agents.
• To discover novel compounds with high binding affinity, improved specificity, and potential efficacy against drug-resistant Mycobacterium tuberculosis strains.
• To integrate computational drug discovery tools to accelerate hit identification and support lead optimization.

Objective:

• To gain insights into current regulatory requirements for new formulation approvals in the pharmaceutical industry.
• To understand the evolving landscape of pharmaceutical regulations through expert interactions and real-world case studies.
• To strengthen knowledge in regulatory affairs and improve awareness of industry compliance standards.

Objective:

• To understand the application of computational tools in drug design and development.
• To gain hands-on knowledge in molecular modelling, virtual screening, and structure-based drug discovery techniques.
• To explore the role of in silico methods in accelerating the drug discovery pipeline.